在患有败血症和败血症休克的重症患者的代谢学方面取得了进展
1Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Clinical and experimental emergency medicine
|July 19, 2024
概括
代谢学提供了对败血症和败血症休克的新见解,改善了诊断和预后. 这项技术分析代谢物,以了解疾病进展,并识别早期生物标志物,以更好地管理患者.
科学领域:
- 临床医学 临床医学
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 败血症是一个重大的临床挑战,患病率和死亡率很高.
- 败血栓性休克是一种严重的败血症,可以迅速导致器官功能障碍和死亡.
- 了解败血症病理生理学对于有效的疾病管理至关重要.
研究的目的:
- 审查在败血症和败血症休克中代谢学的应用.
- 探索新陈代谢分析如何有助于败血症诊断和预后.
- 突出代谢学在识别败血症早期生物标志物的作用.
主要方法:
- 在像PubMed和Scopus这样的数据库中使用关键词"代谢学"",败血症"和"败血症休克"进行文献搜索.
- 从创建到2023年12月的记录分析.
- 在败血症和败血症休克中对代谢概况的信息的综合.
主要成果:
- 代谢学显著提高了对败血症和败血症休克的理解.
- 代谢剖析揭示了毒症诊断的潜在早期生物标志物.
- 代谢药有助于评估预后和治疗败血症患者.
结论:
- 代谢学是解开败血症病理生理学的强大工具.
- 代谢学的应用增强了在败血症护理中的诊断和预后能力.
- 进一步的代谢学研究可以改善败血症患者的治疗结果.
相关概念视频
Blood Studies I: ABG and VBG
Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...


